Lucentis: Clinical Trials

1 trial of Lucentis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Enrolling by invitation 1

Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
Standard of Care, Ranibizumab - Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2Enrolling by invitationAbbVie1162021-12-202026-08-05

Sponsors

AbbVie (1)

Countries

United States (1)